biologic

Remicade

infliximab

Loss of exclusivity—loss of exclusivity
CompanyJanssen Biotech →See this company's full patent-cliff portfolio

Drug detail

Brand nameRemicade
Active ingredientinfliximab
Strength100MG
Dosage formFor Injection
RouteIntravenous
ModalityBiologic
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.